Forian INC. (FORA) — SEC Filings

Overview

Forian INC. (FORA) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a DEF 14A filed on Dec 15, 2025: Forian Inc. (FORA) is seeking stockholder approval to redomicile from Delaware to Maryland via a statutory conversion at a Special Meeting on January 8, 2026. This strategic move, recommended by the Board and a Special Committee, is primarily to facilitate the company's ability to fully consider a '

Sentiment Summary

Across 26 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 22 neutral, 1 mixed. The dominant filing sentiment for Forian INC. is neutral.

Filing Type Overview

Forian INC. (FORA) has filed 13 8-K, 3 DEF 14A, 6 10-Q, 2 10-K, 1 8-K/A, 1 SC 13G/A with the SEC between Feb 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (26)

• 8-K Filing — 8-K · Apr 3, 2026
• Forian to Redomicile to Maryland, Paving Way for Take-Private Deal — DEF 14A · Dec 15, 2025 Risk: low
  Forian Inc. (FORA) is seeking stockholder approval to redomicile from Delaware to Maryland via a statutory conversion at a Special Meeting on January 8, 2026. T
• Forian Revenue Soars 65% Post-Kyber Acquisition, Narrows Net Loss — 10-Q · Nov 14, 2025 Risk: medium
  Forian Inc. reported a significant increase in revenue for both the three and nine months ended September 30, 2025. Revenue for the three months rose to $7,762,
• Forian Inc. Files 8-K for Regulation FD and Financials — 8-K · Aug 25, 2025 Risk: low
  On August 25, 2025, Forian Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company,
• Forian Inc. Reports Director and Officer Changes — 8-K · Aug 20, 2025 Risk: medium
  On August 15, 2025, Forian Inc. filed an 8-K report detailing changes in its board of directors and executive officers. The filing indicates the election of new
• Forian Swings to Profit on Robust Revenue Growth, Kyber Acquisition Boosts Outlook — 10-Q · Aug 14, 2025 Risk: medium
  Forian Inc. (FORA) reported a significant turnaround in its financial performance for the three months ended June 30, 2025, achieving a net income of $224,793,
• Forian Inc. Files 8-K on Financials — 8-K · Aug 13, 2025 Risk: low
  Forian Inc. filed an 8-K on August 13, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. The f
• Forian Inc. Changes Certifying Accountant — 8-K · Jul 1, 2025 Risk: medium
  Forian Inc. filed an 8-K on July 1, 2025, reporting a change in its certifying accountant as of June 26, 2025. The filing indicates a change in the company's in
• Forian Inc. Files 8-K: Director Changes & Executive Compensation — 8-K · Jun 16, 2025 Risk: medium
  Forian Inc. filed an 8-K on June 16, 2025, reporting events as of June 11, 2025. The filing covers the departure and election of directors, appointment of offic
• Forian Inc. Files Q1 2025 10-Q Report — 10-Q · May 15, 2025 Risk: low
  Forian Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, incorporated in Delaware with its principal executive offi
• Forian Inc. Files 8-K on Financials — 8-K · May 14, 2025 Risk: low
  On May 14, 2025, Forian Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financia
• Forian Inc. Reports Executive and Director Changes — 8-K · May 2, 2025 Risk: medium
  On April 28, 2025, Forian Inc. filed an 8-K report detailing changes in its executive and director positions. The filing indicates a departure of directors and
• Forian Inc. Files Definitive Proxy Statement — DEF 14A · Apr 29, 2025 Risk: low
  Forian Inc. filed its definitive proxy statement (DEF 14A) on April 29, 2025, for its annual meeting on June 11, 2025. The filing, which requires no fee, outlin
• Forian Inc. Changes Independent Auditor — 8-K · Apr 28, 2025 Risk: medium
  On April 24, 2025, Forian Inc. reported a change in its certifying accountant. The company dismissed PricewaterhouseCoopers LLP and engaged EisnerAmper LLP as i
• Forian Inc. Files 2024 10-K Report — 10-K · Apr 11, 2025 Risk: medium
  Forian Inc. filed its 2024 10-K report on April 11, 2025, detailing its fiscal year ending December 31, 2024. The company, based in Newtown, PA, operates in com
• Forian Inc. Withdraws Previous Financial Statements — 8-K · Mar 31, 2025 Risk: high
  Forian Inc. filed an 8-K on March 31, 2025, to report that it will not rely on previously issued financial statements or related audit reports. This decision im
• Forian Inc. Amends 8-K Filing — 8-K/A · Jan 16, 2025 Risk: low
  Forian Inc. filed an amendment (8-K/A) on January 16, 2025, to its current report originally filed on October 31, 2024. This amendment pertains to financial sta
• Forian Inc. Files Q3 2024 10-Q Report — 10-Q · Nov 13, 2024 Risk: medium
  Forian Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter. Spe
• Forian Inc. Acquires 06 Technology Assets — 8-K · Nov 6, 2024 Risk: medium
  On October 31, 2024, Forian Inc. announced the completion of its acquisition of substantially all of the assets of 06 Technology. This transaction is expected t
• Forian Inc. Files Q2 2024 10-Q Report — 10-Q · Aug 14, 2024 Risk: medium
  Forian Inc. filed its 10-Q for the period ending June 30, 2024. The filing covers the second quarter and the first six months of the fiscal year. Specific finan
• Forian Inc. Files 8-K on Security Holder Vote Matters — 8-K · Jun 14, 2024 Risk: medium
  On June 12, 2024, Forian Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The company, incorporated in Delaware with it
• Forian Inc. Files Q1 2024 10-Q Report — 10-Q · May 14, 2024 Risk: low
  Forian Inc. (FORA) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Forian Inc. filed its quarterly report on Form 10-Q for the period ending March
• Forian Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 29, 2024 Risk:
  Forian Inc. (FORA) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. Forian Inc. will hold its 2024 Annual Meeting of Stockholders virtually on
• Forian Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 29, 2024 Risk: medium
  Forian Inc. (FORA) filed a Annual Report (10-K) with the SEC on March 29, 2024. Forian Inc. filed its 10-K report for the fiscal year ending December 31, 2023.
• Forian Inc. Files 8-K for Financial Results — 8-K · Mar 28, 2024 Risk: low
  On March 28, 2024, Forian Inc. filed an 8-K report detailing its financial results and exhibits. The company, incorporated in Delaware with its principal execut
• SC 13G/A Filing — SC 13G/A · Feb 13, 2024

Risk Profile

Risk Assessment: Of FORA's 23 recent filings, 1 were flagged as high-risk, 13 as medium-risk, and 9 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Forian INC.'s most recent 10-Q filing (Nov 14, 2025):

• Revenue: $7,762,183
• Net Income: $(151,220)
• Cash Position: $4,660,622
• Total Assets: $41,254,335
• Total Debt: $10,173,704

Key Executives

• Max Wygod
• Caroline McGrail
• Michael Vesey
• Adam Dublin
• Shahir Kassam-Adams

Industry Context

Forian Inc. operates within the healthcare technology sector, focusing on data analytics and software solutions for the life sciences industry. The industry is characterized by rapid technological advancements, increasing regulatory scrutiny, and a trend towards consolidation. Companies in this space often leverage data to improve clinical trial processes, enhance drug discovery, and optimize patient outcomes.

Top Tags

10-Q (4) · financial-reporting (3) · financials (3) · Forian Inc. (3) · Data Analytics (2) · Healthcare Technology (2) · Financial Services (2) · governance (2) · 8-k (2) · auditor-change (2)

Key Numbers

• Special Meeting Date: 2026-01-08 — Date for stockholders to vote on redomiciliation
• Record Date: 2025-12-02 — Date for determining eligible voters for the Special Meeting
• Shares of Common Stock Outstanding: 31,072,252 — Total shares eligible to vote as of the Record Date
• Shares owned by Consortium: 20,654,385 — Represents 66.5% of outstanding common stock, ensuring proposal approval
• Consortium's Beneficial Ownership: 66.5% — Percentage of outstanding common stock owned by the Consortium
• Directors and Officers' Beneficial Ownership: 24.3% — Percentage of outstanding common stock owned by directors and executive officers
• Revenue for Q3 2025: $7,762,183 — Increased 65.6% from $4,686,312 in Q3 2024
• Revenue for nine months ended Sept 30, 2025: $22,294,439 — Increased 55.5% from $14,340,791 in the same period of 2024
• Net loss for Q3 2025: $(151,220) — Improved from a net loss of $(204,907) in Q3 2024
• Net loss for nine months ended Sept 30, 2025: $(1,052,289) — Improved from a net loss of $(3,970,781) in the same period of 2024
• Cash and cash equivalents as of Sept 30, 2025: $4,660,622 — Slight increase from $4,590,661 at Dec 31, 2024
• Marketable securities as of Sept 30, 2025: $23,564,416 — Decreased from $30,492,088 at Dec 31, 2024
• Cash used to redeem convertible notes for nine months ended Sept 30, 2025: $6,840,000 — Significant increase from $950,000 in the same period of 2024
• Shares outstanding as of November 13, 2025: 31,072,252 — Slight decrease from 31,010,788 shares outstanding as of December 31, 2024
• SEC File Number: 001-40146 — Identifies the company's filing with the SEC.

Frequently Asked Questions